SMTL ID : 7l8f.1

BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-2 from animal Rh.33172 (Wk38 time point)

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

hetero-6-1-1-mer

Ligands

3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.1: 9 residues within 4Å: Chain A: K.66, E.213, L.263, N.264, N.378, G.380, V.446, S.447 Ligands: NAG.15 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:V.446 Hydrogen bonds: A:G.380, A:V.446 NAG-NAG-BMA-MAN-MAN.4: 12 residues within 4Å: Chain C: K.66, E.213, V.256, L.263, N.264, N.378, C.379, G.380, C.445, V.446, S.447 Ligands: NAG.33 2 PLIP interactions: 2 interactions with chain C Hydrogen bonds: C:G.380, C:V.446 NAG-NAG-BMA-MAN-MAN.9: 9 residues within 4Å: Chain E: K.66, E.213, V.256, L.263, N.264, G.380, V.446, S.447 Ligands: NAG-NAG.10 2 PLIP interactions: 2 interactions with chain E Hydrogen bonds: E:K.66, E:K.66, E:K.66, E:G.380

11 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.2: 3 residues within 4Å: Chain A: V.136, N.150, Y.167 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:Y.167 NAG-NAG.3: 5 residues within 4Å: Chain A: N.297, T.299, H.331, N.333, R.444 No protein-ligand interaction detected (PLIP) NAG-NAG.5: 3 residues within 4Å: Chain C: Q.295, N.297, N.333 No protein-ligand interaction detected (PLIP) NAG-NAG.6: 4 residues within 4Å: Chain C: V.176, R.194, N.199 Chain E: R.310 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:V.176 NAG-NAG.7: 5 residues within 4Å: Chain C: V.136, N.138, N.150, Y.167, D.322 1 PLIP interactions: 1 interactions with chain C Hydrophobic interactions: C:Y.167 NAG-NAG.8: 4 residues within 4Å: Chain C: N.297, T.299, H.331, N.333 No protein-ligand interaction detected (PLIP) NAG-NAG.10: 4 residues within 4Å: Chain E: N.264, S.293, N.448 Ligands: NAG-NAG-BMA-MAN-MAN.9 No protein-ligand interaction detected (PLIP) NAG-NAG.11: 5 residues within 4Å: Chain E: Q.295, N.297, N.333, V.334, S.335 No protein-ligand interaction detected (PLIP) NAG-NAG.12: 5 residues within 4Å: Chain E: N.150, D.322 Chain G: X.1, X.3, X.26 No protein-ligand interaction detected (PLIP) NAG-NAG.13: 6 residues within 4Å: Chain E: P.301, N.303, V.442 Chain H: X.31, X.50, X.51 No protein-ligand interaction detected (PLIP) NAG-NAG.14: 6 residues within 4Å: Chain E: N.297, T.299, H.331, N.333, S.413, T.415 No protein-ligand interaction detected (PLIP)

49 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.15: 4 residues within 4Å: Chain A: N.264, S.293, N.448 Ligands: NAG-NAG-BMA-MAN-MAN.1 Ligand excluded by PLIP NAG.16: 3 residues within 4Å: Chain A: S.152, F.153, N.154 Ligand excluded by PLIP NAG.17: 2 residues within 4Å: Chain A: N.278, N.281 Ligand excluded by PLIP NAG.18: 3 residues within 4Å: Chain A: Q.295, N.297, N.333 Ligand excluded by PLIP NAG.19: 3 residues within 4Å: Chain A: N.387, S.389 Ligands: NAG.20 Ligand excluded by PLIP NAG.20: 5 residues within 4Å: Chain A: N.364, S.365, T.373, N.387 Ligands: NAG.19 Ligand excluded by PLIP NAG.21: 4 residues within 4Å: Chain A: W.98, N.236, T.238, S.276 Ligand excluded by PLIP NAG.22: 4 residues within 4Å: Chain A: R.194, N.199, T.200 Chain C: R.310 Ligand excluded by PLIP NAG.23: 4 residues within 4Å: Chain A: C.133, T.134, N.135, N.190 Ligand excluded by PLIP NAG.24: 3 residues within 4Å: Chain A: N.303, I.324, V.442 Ligand excluded by PLIP NAG.25: 4 residues within 4Å: Chain A: E.89, N.90 Chain B: G.527, S.528 Ligand excluded by PLIP NAG.26: 1 residues within 4Å: Chain A: N.243 Ligand excluded by PLIP NAG.27: 2 residues within 4Å: Chain A: E.270, N.291 Ligand excluded by PLIP NAG.28: 3 residues within 4Å: Chain A: N.340, T.395, W.396 Ligand excluded by PLIP NAG.29: 2 residues within 4Å: Chain A: S.389, N.393 Ligand excluded by PLIP NAG.30: 3 residues within 4Å: Chain B: K.633, S.636, N.637 Ligand excluded by PLIP NAG.31: 2 residues within 4Å: Chain B: N.618, S.620 Ligand excluded by PLIP NAG.32: 2 residues within 4Å: Chain B: N.611, S.613 Ligand excluded by PLIP NAG.33: 4 residues within 4Å: Chain C: N.264, S.293, N.448 Ligands: NAG-NAG-BMA-MAN-MAN.4 Ligand excluded by PLIP NAG.34: 4 residues within 4Å: Chain C: Q.132, S.152, F.153, N.154 Ligand excluded by PLIP NAG.35: 3 residues within 4Å: Chain C: N.278, T.280, N.281 Ligand excluded by PLIP NAG.36: 4 residues within 4Å: Chain C: T.374, N.387, S.389 Ligands: NAG.37 Ligand excluded by PLIP NAG.37: 5 residues within 4Å: Chain C: N.364, S.365, S.366, G.367 Ligands: NAG.36 Ligand excluded by PLIP NAG.38: 6 residues within 4Å: Chain C: N.236, T.238, I.274, S.276, I.279, H.353 Ligand excluded by PLIP NAG.39: 4 residues within 4Å: Chain C: N.135, G.146, K.149, R.172 Ligand excluded by PLIP NAG.40: 3 residues within 4Å: Chain C: N.303, I.324, V.442 Ligand excluded by PLIP NAG.41: 3 residues within 4Å: Chain C: E.89, N.90 Chain D: S.528 Ligand excluded by PLIP NAG.42: 2 residues within 4Å: Chain C: K.231, N.243 Ligand excluded by PLIP NAG.43: 4 residues within 4Å: Chain C: E.269, E.270, N.291, K.345 Ligand excluded by PLIP NAG.44: 2 residues within 4Å: Chain C: K.348, N.356 Ligand excluded by PLIP NAG.45: 1 residues within 4Å: Chain C: N.393 Ligand excluded by PLIP NAG.46: 3 residues within 4Å: Chain D: S.636, N.637, Y.638 Ligand excluded by PLIP NAG.47: 3 residues within 4Å: Chain D: N.611, S.612, S.613 Ligand excluded by PLIP NAG.48: 4 residues within 4Å: Chain E: Q.132, S.152, F.153, N.154 Ligand excluded by PLIP NAG.49: 3 residues within 4Å: Chain E: N.278, T.280, N.281 Ligand excluded by PLIP NAG.50: 4 residues within 4Å: Chain E: N.387, S.389, R.419 Ligands: NAG.51 Ligand excluded by PLIP NAG.51: 5 residues within 4Å: Chain E: N.364, S.365, T.373, N.387 Ligands: NAG.50 Ligand excluded by PLIP NAG.52: 3 residues within 4Å: Chain E: N.236, T.238, P.240 Ligand excluded by PLIP NAG.53: 4 residues within 4Å: Chain A: R.310 Chain E: R.194, N.199, T.200 Ligand excluded by PLIP NAG.54: 3 residues within 4Å: Chain E: N.135, G.146, K.149 Ligand excluded by PLIP NAG.55: 3 residues within 4Å: Chain E: N.90 Chain F: G.527, S.528 Ligand excluded by PLIP NAG.56: 1 residues within 4Å: Chain E: N.243 Ligand excluded by PLIP NAG.57: 6 residues within 4Å: Chain E: E.269, E.270, N.291, E.292, K.345, K.348 Ligand excluded by PLIP NAG.58: 3 residues within 4Å: Chain E: N.340, S.394, W.396 Ligand excluded by PLIP NAG.59: 2 residues within 4Å: Chain E: K.352, N.356 Ligand excluded by PLIP NAG.60: 2 residues within 4Å: Chain E: S.389, N.393 Ligand excluded by PLIP NAG.61: 1 residues within 4Å: Chain F: N.637 Ligand excluded by PLIP NAG.62: 2 residues within 4Å: Chain F: N.618, S.620 Ligand excluded by PLIP NAG.63: 4 residues within 4Å: Chain F: N.611, S.613, W.614, Y.638 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Antanasijevic, A. et al., Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nat Commun (2021)

Release Date

2021-08-04

Peptides

Envelope glycoprotein gp160: ABCDEF
Rh.33172 pAbC-2 Heavy Chain: G
Rh.33172 pAbC-2 Light Chain: H

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

C
E

D
F

E
A

F
B

G
H

H
L

Envelope glycoprotein gp160

Rh.33172 pAbC-2 Heavy Chain

Rh.33172 pAbC-2 Light Chain

Related Entries With Identical Sequence